Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypersensitivity Reaction

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    February 2019
  1. FAIZ S, Giovannelli J, Podevin C, Jachiet M, et al
    Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
    J Am Acad Dermatol. 2019 Feb 27. pii: S0190-9622(19)30345.
    PubMed     Text format     Abstract available


  2. BRIDGMAN AC, Qureshi A, Li T, Tabung FK, et al
    Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: a cohort study.
    J Am Acad Dermatol. 2019 Feb 21. pii: S0190-9622(19)30329.
    PubMed     Text format     Abstract available


  3. MADIGAN LM, Fox LP
    Vancomycin-associated Drug-Induced Hypersensitivity Syndrome (DIHS).
    J Am Acad Dermatol. 2019 Feb 6. pii: S0190-9622(19)30197.
    PubMed     Text format     Abstract available


  4. LISZEWSKI W, Warshaw EM
    Pigments in American Tattoo Inks and their Propensity to Elicit Allergic Contact Dermatitis.
    J Am Acad Dermatol. 2019 Feb 4. pii: S0190-9622(19)30189.
    PubMed     Text format     Abstract available


    January 2019
  5. HUGHES ME, Aralis H, Bruhn KW, Cotliar J, et al
    "A Reliability Study Using Network-Oriented Research Assistant (NORA((R))) to Evaluate the Use of Digital Photographs in the Assessment of Atopic Dermatitis".
    J Am Acad Dermatol. 2019 Jan 28. pii: S0190-9622(19)30150.
    PubMed     Text format    


  6. CHIPALKATTI N, Lee N, Zancanaro P, Dumont N, et al
    A Retrospective Review of Dupilumab for Atopic Dermatitis Patients with Allergic Contact Dermatitis.
    J Am Acad Dermatol. 2019 Jan 7. pii: S0190-9622(19)30011.
    PubMed     Text format    


  7. PEPPERS J, Paller AS, Maeda-Chubachi T, Wu S, et al
    A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis.
    J Am Acad Dermatol. 2019;80:89-98.
    PubMed     Text format     Abstract available


    December 2018
  8. SIMPSON EL, Parnes JR, She D, Crouch S, et al
    Tezepelumab, an anti-TSLP monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial.
    J Am Acad Dermatol. 2018 Dec 11. pii: S0190-9622(18)33050.
    PubMed     Text format     Abstract available


  9. SIEGEL J, Totonchy M, Damsky W, Berk-Krauss J, et al
    Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
    J Am Acad Dermatol. 2018;79:1081-1088.
    PubMed     Text format     Abstract available


  10. KIM WB, Worley B, Holmes J, Phillips EJ, et al
    Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Am Acad Dermatol. 2018;79:1150-1152.
    PubMed     Text format    


  11. ROSEN JD, Fostini AC, Chan YH, Nattkemper LA, et al
    Cross-sectional study of clinical distinctions between neuropathic and inflammatory pruritus.
    J Am Acad Dermatol. 2018;79:1143-1144.
    PubMed     Text format    


  12. MIN LEE CK, Li S, Tran DC, Zhu GA, et al
    Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study.
    J Am Acad Dermatol. 2018;79:1047-1052.
    PubMed     Text format     Abstract available


  13. NELSON CA, Stephen S, Ashchyan HJ, James WD, et al
    Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behcet disease.
    J Am Acad Dermatol. 2018;79:987-1006.
    PubMed     Text format     Abstract available


    November 2018
  14. SERRANO L, Patel KR, Silverberg JI
    Association between atopic dermatitis and extra-cutaneous bacterial and mycobacterial infections: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018 Nov 21. pii: S0190-9622(18)32954.
    PubMed     Text format     Abstract available


  15. COUTEAU C, Coiffard LJM
    Are alkyl glucosides really allergens?
    J Am Acad Dermatol. 2018 Nov 14. pii: S0190-9622(18)32895.
    PubMed     Text format    


  16. HEYMANN WR
    "Tar Smarts" May Have a New Meaning for Atopic Dermatitis and Psoriasis.
    J Am Acad Dermatol. 2018 Nov 2. pii: S0190-9622(18)32828.
    PubMed     Text format    


    October 2018
  17. LAKE E
    Game Changer: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    J Am Acad Dermatol. 2018 Oct 30. pii: S0190-9622(18)32822.
    PubMed     Text format    


  18. PATEL KR, Immaneni S, Singam V, Rastogi S, et al
    Association between atopic dermatitis, depression and suicidal ideation: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018 Oct 23. pii: S0190-9622(18)32758.
    PubMed     Text format     Abstract available


  19. SEGER EW, Wechter T, Strowd L, Feldman SR, et al
    Relative efficacy of systemic treatments for atopic dermatitis.
    J Am Acad Dermatol. 2018 Oct 5. pii: S0190-9622(18)32669.
    PubMed     Text format     Abstract available


  20. FLEISCHER AB JR
    Guideline-Based Medicine Grading based upon the Guidelines of Care for Ambulatory Atopic Dermatitis Treatment in the United States.
    J Am Acad Dermatol. 2018 Oct 1. pii: S0190-9622(18)32636.
    PubMed     Text format     Abstract available


  21. NARLA S, Silverberg JI
    Association between atopic dermatitis and autoimmune disorders in US adults and children: A cross-sectional study.
    J Am Acad Dermatol. 2018 Oct 1. pii: S0190-9622(18)32635.
    PubMed     Text format     Abstract available


  22. YEW YW, Thyssen JP, Silverberg JI
    A systematic review and meta-analysis of the regional and age-related differences of atopic dermatitis clinical characteristics.
    J Am Acad Dermatol. 2018 Oct 1. pii: S0190-9622(18)32645.
    PubMed     Text format     Abstract available


  23. LEE HY
    Wound management strategies in Stevens-Johnson syndrome/toxic epidermal necrolysis: An unmet need.
    J Am Acad Dermatol. 2018;79:e87-e88.
    PubMed     Text format    


  24. CASTILLO B, Vera N, Ortega-Loayza AG, Seminario-Vidal L, et al
    Reply to: "Wound management strategies in Stevens-Johnson syndrome/toxic epidermal necrolysis: An unmet need".
    J Am Acad Dermatol. 2018;79:e89.
    PubMed     Text format    


  25. ANTIA C, Baquerizo K, Korman A, Alikhan A, et al
    Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes.
    J Am Acad Dermatol. 2018;79:617-633.
    PubMed     Text format     Abstract available


  26. ANTIA C, Baquerizo K, Korman A, Bernstein JA, et al
    Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up.
    J Am Acad Dermatol. 2018;79:599-614.
    PubMed     Text format     Abstract available


  27. WARSHAW EM, Aschenbeck KA, DeKoven JG, Maibach HI, et al
    Epidemiology of pediatric nickel sensitivity: Retrospective review of North American Contact Dermatitis Group (NACDG) data 1994-2014.
    J Am Acad Dermatol. 2018;79:664-671.
    PubMed     Text format     Abstract available


  28. BJERRE RD, Ulrich NH, Linneberg A, Duus Johansen J, et al
    Adverse reactions to tattoos in the general population of Denmark.
    J Am Acad Dermatol. 2018;79:770-772.
    PubMed     Text format    


  29. CASTILLO B, Vera N, Ortega-Loayza AG, Seminario-Vidal L, et al
    Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Am Acad Dermatol. 2018;79:764-767.
    PubMed     Text format    


    September 2018
  30. MIZUKAWA Y, Hirahara K, Kano Y, Shiohara T, et al
    Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease.
    J Am Acad Dermatol. 2018 Sep 18. pii: S0190-9622(18)32585.
    PubMed     Text format     Abstract available


  31. RONNSTAD ATM, Halling-Overgaard AS, Hamann CR, Skov L, et al
    Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018;79:448-456.
    PubMed     Text format     Abstract available


  32. STEINKE S, Zeidler C, Riepe C, Bruland P, et al
    Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.
    J Am Acad Dermatol. 2018;79:457-463.
    PubMed     Text format     Abstract available


  33. HOSKING AM, Juhasz M, Mesinkovska NA
    Topical Janus kinase inhibitors: A review of applications in dermatology.
    J Am Acad Dermatol. 2018;79:535-544.
    PubMed     Text format     Abstract available


  34. RZEPECKI AK, Cheng H, McLellan BN
    Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy.
    J Am Acad Dermatol. 2018;79:545-555.
    PubMed     Text format     Abstract available


  35. KUMARAN MS, Razmi T M, Vinay K, Parsad D, et al
    Clinical, dermoscopic, and trichoscopic analysis of frontal fibrosing alopecia associated with acquired dermal macular hyperpigmentation: A cross sectional observational case-control study.
    J Am Acad Dermatol. 2018;79:588-591.
    PubMed     Text format    


  36. TSAI TY, Huang YC
    Vitamin D deficiency in patients with chronic and acute urticaria: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2018;79:573-575.
    PubMed     Text format    


  37. MAXIM E, Aksut C, Tsoi D, Dellavalle R, et al
    Global burden of urticaria: Insights from the 2016 Global Burden of Disease Study.
    J Am Acad Dermatol. 2018;79:567-569.
    PubMed     Text format    


    August 2018
  38. MACHLER BC, Sung CT, Darwin E, Jacob SE, et al
    Dupilumab use in allergic contact dermatitis.
    J Am Acad Dermatol. 2018 Aug 6. pii: S0190-9622(18)32345.
    PubMed     Text format    


  39. BLAUVELT A, Simpson EL, Tyring SK, Purcell LA, et al
    Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.
    J Am Acad Dermatol. 2018 Aug 6. pii: S0190-9622(18)32351.
    PubMed     Text format     Abstract available


  40. BREGEON B, Bernier C, Josselin N, Peuvrel L, et al
    DRESS syndrome induced by the combination of vemurafenib and cobimetinib in melanoma: a series of 11 cases.
    J Am Acad Dermatol. 2018 Aug 3. pii: S0190-9622(18)32329.
    PubMed     Text format    


  41. SIMPSON EL, Reynolds NJ, Flohr C, Paller AS, et al
    Response to "Comment on: 'When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council'".
    J Am Acad Dermatol. 2018;79:e25-e26.
    PubMed     Text format    


  42. DAUNTON A, Goulding JMR
    Comment on: "When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council".
    J Am Acad Dermatol. 2018;79:e23-e24.
    PubMed     Text format    


    July 2018
  43. RASTOGI S, Patel KR, Singam V, Silverberg JI, et al
    Allergic Contact Dermatitis To Personal Care Products And Topical Medications In Adults With Atopic Dermatitis.
    J Am Acad Dermatol. 2018 Jul 24. pii: S0190-9622(18)32316.
    PubMed     Text format     Abstract available


  44. VASHI NA, Patzelt N, Wirya S, Maymone MBC, et al
    Dermatoses caused by cultural practices: Cosmetic cultural practices.
    J Am Acad Dermatol. 2018;79:19-30.
    PubMed     Text format     Abstract available


    June 2018
  45. ZIRWAS M, Dobkin H
    2-methoxymethyl-para-phenylenediamine containing hair dye as a less allergenic alternative for para-phenylenediamine allergic individuals.
    J Am Acad Dermatol. 2018 Jun 16. pii: S0190-9622(18)32141.
    PubMed     Text format    


  46. LEE HH, Patel KR, Singam V, Rastogi S, et al
    A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis.
    J Am Acad Dermatol. 2018 Jun 1. pii: S0190-9622(18)32046.
    PubMed     Text format     Abstract available


  47. PHILLIPS GS, Freites-Martinez A, Hsu M, Skripnik Lucas A, et al
    Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients.
    J Am Acad Dermatol. 2018;78:1102-1109.
    PubMed     Text format     Abstract available


  48. NETTIS E, Di Leo E, Foti C, Cegolon L, et al
    Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria.
    J Am Acad Dermatol. 2018;78:1211-1213.
    PubMed     Text format    


    May 2018
  49. MCKENZIE C, Silverberg JI
    Association of family structure with atopic dermatitis in United States children.
    J Am Acad Dermatol. 2018 May 31. pii: S0190-9622(18)30835.
    PubMed     Text format     Abstract available


  50. KWA L, Silverberg JI
    Financial burden of emergency department visits for atopic dermatitis in the United States.
    J Am Acad Dermatol. 2018 May 22. pii: S0190-9622(18)30821.
    PubMed     Text format     Abstract available


  51. SHAHEEN MS, Silverberg JI
    Atopic dermatitis is associated with osteoporosis and osteopenia in older adults.
    J Am Acad Dermatol. 2018 May 22. pii: S0190-9622(18)30822.
    PubMed     Text format    


    April 2018
  52. HEYMANN WR
    Keeping an eye on atopic dermatitis.
    J Am Acad Dermatol. 2018 Apr 19. pii: S0190-9622(18)30628.
    PubMed     Text format    


  53. FISHBEIN AB, Lin B, Beaumont J, Paller AS, et al
    Nocturnal Movements in Children with Atopic Dermatitis have a Timing Pattern: A Case Control Study.
    J Am Acad Dermatol. 2018 Apr 16. pii: S0190-9622(18)30564.
    PubMed     Text format    


  54. CASALE TB, Win PH, Bernstein JA, Rosen K, et al
    Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.
    J Am Acad Dermatol. 2018;78:793-795.
    PubMed     Text format    


    March 2018
  55. FREEMYER B, Drozd B, Suarez A
    A cross-sectional study of YouTube videos about atopic dermatitis.
    J Am Acad Dermatol. 2018;78:612-613.
    PubMed     Text format    


  56. GOODERHAM MJ, Hong HC, Eshtiaghi P, Papp KA, et al
    Dupilumab: A review of its use in the treatment of atopic dermatitis.
    J Am Acad Dermatol. 2018;78.
    PubMed     Text format     Abstract available


  57. PALLER AS, Czarnowicki T, Renert-Yuval Y, Holland K, et al
    The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab.
    J Am Acad Dermatol. 2018;78:498-505.
    PubMed     Text format     Abstract available


  58. ZEBDA R, Paller AS
    Phosphodiesterase 4 inhibitors.
    J Am Acad Dermatol. 2018;78.
    PubMed     Text format     Abstract available


    February 2018
  59. JEON HS, Choi M, Byun SJ, Suh LH, et al
    Atopic Dermatitis is Not a Risk Factor for Keratoconus: A Population-based Cohort Study.
    J Am Acad Dermatol. 2018 Feb 22. pii: S0190-9622(18)30324.
    PubMed     Text format    


  60. GUTTMAN-YASSKY E, Silverberg JI, Nemoto O, Forman SB, et al
    Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.
    J Am Acad Dermatol. 2018 Feb 1. pii: S0190-9622(18)30129.
    PubMed     Text format     Abstract available


  61. ZINN Z, Gayam S, Chelliah MP, Honari G, et al
    Patch testing for nonimmediate cutaneous adverse drug reactions.
    J Am Acad Dermatol. 2018;78:421-423.
    PubMed     Text format    


  62. BOGGIO F, Lora V, Cota C, Pereira A, et al
    Cutaneous hemophagocytosis: Clinicopathologic features of 21 cases.
    J Am Acad Dermatol. 2018;78:377-382.
    PubMed     Text format     Abstract available


    January 2018
  63. SIMPSON EL, Flohr C, Eichenfield LF, Bieber T, et al
    Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
    J Am Acad Dermatol. 2018 Jan 15. pii: S0190-9622(18)30102.
    PubMed     Text format     Abstract available


  64. GUTTMAN-YASSKY E, Brunner PM, Neumann AU, Khattri S, et al
    Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial.
    J Am Acad Dermatol. 2018 Jan 15. pii: S0190-9622(18)30101.
    PubMed     Text format     Abstract available


  65. HE A, Feldman SR, Fleischer AB Jr.
    An assessment of the use of antihistamines in the management of atopic dermatitis.
    J Am Acad Dermatol. 2018 Jan 6. pii: S0190-9622(18)30020.
    PubMed     Text format     Abstract available


  66. ST JOHN J, Vedak P, Garza-Mayers AC, Hoang MP, et al
    Location of skin lesions in Henoch-Schonlein purpura and its association with significant renal involvement.
    J Am Acad Dermatol. 2018;78:115-120.
    PubMed     Text format     Abstract available


  67. MITTAL L, Zhang L, Feng R, Werth VP, et al
    Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    J Am Acad Dermatol. 2018;78:100-106.
    PubMed     Text format     Abstract available


    December 2017
  68. BONCHAK JG, Swerlick RA
    Emerging Therapies for Atopic Dermatitis: TRPV1 Antagonists.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32825.
    PubMed     Text format     Abstract available


  69. YANES DA, Mosser-Goldfarb JL
    Emerging Therapies for Atopic Dermatitis: The Prostaglandin/Leukotriene Pathway.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32822.
    PubMed     Text format     Abstract available


  70. HAMANN CR, Thyssen JP
    Monoclonal Antibodies Against IL-13 and IL-31RA in Development for Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32819.
    PubMed     Text format     Abstract available


  71. VAKHARIA PP, Silverberg JI
    New Therapies for Atopic Dermatitis: Additional Treatment Classes.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32826.
    PubMed     Text format     Abstract available


  72. TIDWELL WJ, Fowler JF Jr
    T-Cell Inhibitors for Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32821.
    PubMed     Text format     Abstract available


  73. COTTER DG, Schairer D, Eichenfield L
    Emerging Therapies for Atopic Dermatitis: Jak Inhibitors.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32820.
    PubMed     Text format     Abstract available


  74. ZIRWAS MJ
    The Future is Finally Here: Advances in the Treatment of Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32827.
    PubMed     Text format    


  75. FAINA V, Paolino G, Bavastrelli M, Calvieri S, et al
    Classification of cutaneous manifestations in patients with non-celiac gluten sensitivity (NCGS) and wheat allergy (WA).
    J Am Acad Dermatol. 2017 Dec 13. pii: S0190-9622(17)32811.
    PubMed     Text format    


    November 2017
  76. THYSSEN JP, Skov L, Egeberg A
    Cause specific mortality in adults with atopic dermatitis.
    J Am Acad Dermatol. 2017 Nov 1. pii: S0190-9622(17)32590.
    PubMed     Text format     Abstract available


  77. RICKSTREW J, Wang T, Liu D, Rajpara A, et al
    Mitigation or prevention of mild hair dye contact dermatitis after pretreatment with clobetasol foam.
    J Am Acad Dermatol. 2017;77:e129.
    PubMed     Text format    


  78. LAM BD, Miller MM, Sutton AV, Peng D, et al
    Vancomycin and DRESS: A retrospective chart review of 32 cases in Los Angeles, California.
    J Am Acad Dermatol. 2017;77:973-975.
    PubMed     Text format    


    October 2017
  79. FISHBEIN AB, Mueller K, Kruse L, Boor P, et al
    Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study.
    J Am Acad Dermatol. 2017 Oct 28. pii: S0190-9622(17)32306.
    PubMed     Text format     Abstract available


  80. BOOZALIS E, Patel S
    "Allergen of the Year" alkyl glucoside is an ingredient in top-selling sunscreens and facial moisturizers.
    J Am Acad Dermatol. 2017 Oct 14. pii: S0190-9622(17)32539.
    PubMed     Text format    


  81. YU S, Drucker AM, Lebwohl M, Silverberg JI, et al
    A systematic review of safety and efficacy of systemic corticosteroids in atopic dermatitis.
    J Am Acad Dermatol. 2017 Oct 12. pii: S0190-9622(17)32533.
    PubMed     Text format     Abstract available


  82. ECKERT L, Gupta S, Amand C, Gadkari A, et al
    The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey.
    J Am Acad Dermatol. 2017 Oct 7. pii: S0190-9622(17)32181.
    PubMed     Text format     Abstract available


  83. FLEMING P, Drucker AM
    Risk of Infection in Patients with Atopic Dermatitis Treated with Dupilumab: A Meta-Analysis of Randomized Controlled Trials.
    J Am Acad Dermatol. 2017 Oct 4. pii: S0190-9622(17)32457.
    PubMed     Text format     Abstract available


  84. KONG BY, Immaneni S, Paller AS, Xu S, et al
    Potential impact of biologics and emerging therapies for psoriasis and atopic dermatitis on future fertility: Reassurance to patients but more data are needed.
    J Am Acad Dermatol. 2017;77:758-763.
    PubMed     Text format    


  85. SILVERBERG JI, Hsu DY, Brieva J, Silverberg NB, et al
    Reply to: "Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis".
    J Am Acad Dermatol. 2017;77:e119.
    PubMed     Text format    


  86. SCHNEIDER JA, Cohen PR
    Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Am Acad Dermatol. 2017;77:e117.
    PubMed     Text format    


  87. HSU CY, Lee WR, Shih YH
    Recalcitrant chronic leg ulcer: An indication for patch testing for hydrocolloid dressing.
    J Am Acad Dermatol. 2017;77:e97-e98.
    PubMed     Text format    


  88. CHANSKY PB, Wanat K, Pappas-Taffer L, Rosenbach M, et al
    A cross-sectional survey of voriconazole prescribers: Assessing current practice and knowledge of cutaneous side effects.
    J Am Acad Dermatol. 2017;77:769-770.
    PubMed     Text format    


    September 2017
  89. BELUM VR, Marchetti MA, Dusza SW, Cercek A, et al
    A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.
    J Am Acad Dermatol. 2017;77:577-579.
    PubMed     Text format    


    July 2017
  90. OLIVER B, Free R, Aires D
    Preapplication of white petroleum jelly to adjacent skin to prevent aluminum chloride-induced irritant dermatitis.
    J Am Acad Dermatol. 2017;77:e7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: